Search results

179 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC researchers discover how body temperature wrecks potential dengue, Zika vaccine
The UNC School of Medicine labs of Brian Kuhlman, PhD, and Aravinda de Silva, PhD, found that key components of a potentially potent vaccine fall apart due to body temperature, leaving us susceptible to severe infection.
Located in News / 2018 / May
Researchers Pinpoint Animal Model Proteins Important in Study of Human Disease
Frank Conlon, PhD, co-led a study showing which proteins and pathways are conserved in four major animal models and humans, providing insights into which models are best for specific research of human disease.
Located in News / 2019 / September
Some e-cigarette ingredients are surprisingly more toxic than others
UNC School of Medicine scientists led by Robert Tarran created a new screening technique to deduce the different toxicity levels of the more than 7,700 types of e-liquid flavors available to consumers.
Located in News / 2018 / March
If You Could Learn Every Disease Your Child Could Possibly Develop in Life, Would You?
Adding genomic sequencing results to traditional newborn screening means a baby could potentially test positive for numerous conditions that might not develop within their lifetime. A UNC School of Medicine study proposed a method for how to responsibly determine which types of conditions to include in testing and potentially return to parents.
Located in News / 2019 / May
UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV Diagnostic Assay
The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research (SBIR) contract from the National Institutes of Health (NIH) to develop an automated platform to quantify the latent HIV reservoir.
Located in Vital Signs / 2018 / Sept. 13
Inaugural Class of UNC Physician Assistant Program Featured by Blue Cross and Blue Shield of NC
An article published on the BCBS website focuses on one upcoming graduate’s experience in the program, her motivation for pursuing a career as a physician assistant, and her goals after graduating this December.
Located in News / 2017 / November
Nash UNC Health Care Names L. Lee Isley as CEO
Isley has served as CEO for Granville Health System in Oxford, NC, since 2006, and has held a variety of roles in his 30-year health care career.
Located in News / 2018 / January
Researchers continue to seek strategy for starving brain tumors
In the journal Cancer Research, UNC Lineberger researchers led by member Timothy R. Gershon, MD, PhD, report in the latest in a series of attempts to shut down the energy production machinery in medulloblastoma, the most common malignant brain tumor in children. The findings may help researchers identify a suitable therapeutic target within the sugar metabolism pathway, and provide clues to a scientific mystery surrounding the confounding way that some cancer cells get energy from sugar.
Located in News / 2017 / June
Payments linked to higher odds of doctors prescribing certain cancer drugs
In preliminary findings that will be presented at the American Society of Clinical Oncology Annual Meeting 2017 in Chicago on Saturday, June 3, researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.
Located in News / 2017 / June
Dengue Fever Vaccine Delivered With Nanotechnology Targets All Four Virus Serotypes
A newly published study led by Stefan Metz, PhD, a research associate at the UNC School of Medicine, details how researchers used a nanoparticle vaccine platform to develop a tetravalent dengue virus vaccine capable of inducing balanced, type-specific neutralizing antibodies to each dengue virus serotype.
Located in News / 2018 / October